3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
2
Conditions
Stomach Neoplasms
15
Colorectal Neoplasms
15
Pancreatic Neoplasms
11
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Esophageal Neoplasms
6
Rectal Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Anus Neoplasms
4
Neoplasms
3
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Peritoneal Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Interventions
Light Coagulation
3
Watchful Waiting
2
Observation
2
VGX-3100
1
Polymerase Chain Reaction
1
Laser Therapy
1
Imiquimod
1
Gene Expression Profiling
1
Fluorouracil
1
DNA Methylation
1
Cidofovir
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Squamous Intraepithelial Lesions
×
Observation
×
Gastrointestinal
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled